Biovail's Steinbach Manufacturing Facility Receives Prestigious Manitoba Business Award

    TORONTO, November 1 /CNW/ - Biovail Corporation (NYSE:BVF) (TSX:BVF)
today announced that the Company's manufacturing facility in Steinbach,
Manitoba, has been named the province's Outstanding Large Business in the 2007
Manitoba Business Awards competition, presented by the Manitoba Chamber of
Commerce.

    Biovail received the honor at a gala in Winnipeg.

    "Biovail's manufacturing facility in Steinbach produces many of Biovail's
leading branded pharmaceutical products, including Wellbutrin XL(R), Ultram(R)
ER, Cardizem(R) LA and Tiazac(R) XC; as such, it plays a critically important
role in Company operations," says Biovail Chief Executive Officer Dr. Douglas
Squires. "On behalf of the executive management team, I'd like to congratulate
the leadership team and all our employees at Steinbach.

    "We are proud of the relationship we have developed with both Steinbach
and the Province of Manitoba. The receipt of this prestigious award is
testament to the hard work of each and every Biovail employee in Steinbach. We
are very pleased and honored to receive it."

    About Biovail Corporation

    Biovail Corporation is a specialty pharmaceutical company, engaged in the
formulation, clinical testing, registration, manufacture, and
commercialization of pharmaceutical products utilizing advanced drug-delivery
technologies. For more information about Biovail, visit the Company's Web site
at www.biovail.com.

    For further information, please contact Nelson F. Isabel at 905-286-3000
or send inquiries to ir@biovail.com.

For further information: Biovail Corporation Nelson F. Isabel,
905-286-3000 Vice-President, Investor Relations and Corporate Communications